Rapid Intracranial Response to Osimertinib in a Patient with Epidermal Growth Factor Receptor T790M-Positive Adenocarcinoma of the Lung

Publisher： Karger

E-ISSN： 2296-5262|39|7-8|461-463

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.39, Iss.7-8, 2016-06, pp. : 461-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2090-2098

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma

By  

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-09 ,pp. : 450-455

Karger

Access to resources Recommend Favorite

Human Epidermal Growth Factor Receptor 2-Positive Duodenal Adenocarcinoma: A Case Report and Review of the Literature

By  

Case Reports in Oncology, Vol. 8, Iss. 2, 2015-07 ,pp. : 285-289

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor-GEP100-Arf6 Axis Affects the Prognosis of Lung Adenocarcinoma

By  

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 263-270

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-05 ,pp. : 263-268

Karger

Access to resources Recommend Favorite